US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

4.56

+0.22005.07%

Pre-market: 4.680.1201+2.63%09:17 EST

Volume:69.34K

Turnover:312.48K

Market Cap:14.04M

PE:-0.06

High:4.70

Open:4.40

Low:4.33

Close:4.34

52wk High:55.50

52wk Low:3.13

Shares:3.08M

Float Shares:3.03M

Volume Ratio:1.73

T/O Rate:2.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-78.8608

EPS(LYR):-158.0236

ROE:-503.80%

ROA:-69.18%

PB:-0.52

PE(LYR):-0.03

Loading ...

Overview Company News Filings

BRIEF-Moleculin Miracle Trial Delivers 40% Preliminary Blinded CRc Rate (N=30)

Moleculin Biotech Inc - Reports 40% Preliminary Crc Rate in Miracle Trial

THOMSON REUTERS

Moleculin Biotech Inc - Expects Recruitment of First 45 Subjects by Q1 2026

THOMSON REUTERS

Moleculin MIRACLE trial reports 40% preliminary blinded CRc rate in relapsed or refractory AML

Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin

THOMSON REUTERS

Moleculin Biotech Receives Notice of Allowance for Japanese Patent Covering Liposomal Annamycin

Moleculin Biotech Inc. Launches CEO Corner to Enhance Stakeholder Communication and Outlines Plans to Advance Lead Clinical Programs and Pipeline Development

Moleculin Biotech Inc. Held Special Stockholder Meeting

Moleculin Biotech nimmt an virtueller Corporate-Connect-Konferenz von Webull Financial teil

BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials

Moleculin Biotech Reports Annamycin Shows No Cardiotoxicity in 90 Clinical Trial Subjects

BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical Programs

Moleculin Biotech Inc - First Miracle Trial Unblinding Expected Q1 2026; Global Trial NOW Spans Nine Countries

THOMSON REUTERS

Moleculin Biotech Inc - Primary Efficacy Data for Miracle Expected in 2028

THOMSON REUTERS

BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance

Moleculin Biotech Inc - Regains Nasdaq Listing Compliance - SEC Filing

THOMSON REUTERS

Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting

Moleculin Reports Positive Phase 1 Results for WP1066 in Pediatric Brain Tumors

Moleculin Biotech Inc - WP1066 Found Safe and Effective, Warranting Phase 2 Trial

THOMSON REUTERS

Moleculin Announces Positive Results From Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech","latestPrice":4.56,"timestamp":1771362000000,"preClose":4.34,"halted":0,"volume":69344,"hourTrading":{"tag":"盘前","latestPrice":4.6801,"preClose":4.56,"latestTime":"09:17 EST","volume":22664,"amount":108306.83652,"timestamp":1771424245440,"change":0.1201,"changeRate":0.026338,"amplitude":0.101272},"delay":0,"changeRate":0.05069124423963128,"floatShares":3034900,"shares":3079200,"eps":-78.860825,"marketStatus":"Pre-Mkt","change":0.22,"latestTime":"02-18 09:18:55 EST","open":4.4,"high":4.7,"low":4.33,"amount":312477.9328,"amplitude":0.085253,"askPrice":4.99,"askSize":2,"bidPrice":4.5,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-78.860825,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771425000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.56,"preHourTrading":{"tag":"盘前","latestPrice":4.6801,"preClose":4.56,"latestTime":"09:17 EST","volume":22664,"amount":108306.83652,"timestamp":1771424245440,"change":0.1201,"changeRate":0.026338,"amplitude":0.101272},"postHourTrading":{"tag":"盘后","latestPrice":4.65,"preClose":4.56,"latestTime":"19:03 EST","volume":2464,"amount":11117.81,"timestamp":1771372997374,"change":0.09,"changeRate":0.019737,"amplitude":0.054825},"volumeRatio":1.7338340745353984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","floatShares":3034900,"roa":"-69.18%","roe":"-503.80%","lyrEps":-158.02365,"volumeRatio":1.7338340745353984,"shares":3079200,"dividePrice":0,"high":4.7,"amplitude":0.085253,"preClose":4.34,"low":4.33,"week52Low":3.13,"pbRate":"-0.52","week52High":55.5,"institutionHeld":0,"latestPrice":4.56,"committee":-0.333333,"eps":-78.860825,"divideRate":0,"volume":69344,"delay":0,"ttmEps":-78.860825,"open":4.4,"prevYearClose":3.31,"prevWeekClose":4.34,"prevMonthClose":4.29,"prevQuarterClose":3.31,"fiveDayClose":4.12,"twentyDayClose":4.16,"sixtyDayClose":10.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-01","symbol":"MBRX","defaultRemindTime":1764599400000,"type":"split","dateTimestamp":1764565200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-11-13","symbol":"MBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-08-12","symbol":"MBRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.49},{"date":"2025-05-14","symbol":"MBRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"defaultRemindTime":1747209600000,"name":null,"time":"Pre-Market","dateTimestamp":1747195200000,"actualEps":-0.69},{"date":"2025-03-24","symbol":"MBRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-1.29,"defaultRemindTime":1742803200000,"name":null,"time":"Pre-Market","dateTimestamp":1742788800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743138000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBRX","date":"2026-02-17","current":-0.057823,"percent":0.887797,"low":-7.721761,"twenty":-3.196948,"median":-0.830495,"eighty":-0.375032,"high":-0.041817,"avg":-1.761137,"sd":1.85741,"marketCap":13363853},"quantilePoints":[{"date":"2021-02-19","current":-7.568247,"twenty":-7.421831,"median":-4.051721,"eighty":-2.914212,"marketCap":140110959},{"date":"2021-02-26","current":-6.493648,"twenty":-7.421831,"median":-4.067696,"eighty":-2.934119,"marketCap":120216908},{"date":"2021-03-05","current":-5.940997,"twenty":-7.321958,"median":-4.075277,"eighty":-2.939251,"marketCap":109985682},{"date":"2021-03-12","current":-6.816028,"twenty":-7.267317,"median":-4.075277,"eighty":-2.940877,"marketCap":126185124},{"date":"2021-03-19","current":-6.340134,"twenty":-7.246835,"median":-4.100664,"eighty":-2.943519,"marketCap":117374901},{"date":"2021-03-26","current":-6.277277,"twenty":-7.195277,"median":-4.12239,"eighty":-2.948181,"marketCap":108942147},{"date":"2021-04-01","current":-6.654242,"twenty":-7.154554,"median":-4.134797,"eighty":-2.95472,"marketCap":115484365},{"date":"2021-04-09","current":-6.211718,"twenty":-7.101216,"median":-4.144871,"eighty":-2.95472,"marketCap":107804370},{"date":"2021-04-16","current":-5.638077,"twenty":-7.011134,"median":-4.180688,"eighty":-2.956046,"marketCap":97848822},{"date":"2021-04-23","current":-5.736415,"twenty":-6.994135,"median":-4.216616,"eighty":-2.961351,"marketCap":99555487},{"date":"2021-04-30","current":-5.752805,"twenty":-6.968887,"median":-4.283448,"eighty":-2.961632,"marketCap":99839931},{"date":"2021-05-07","current":-5.490569,"twenty":-6.958418,"median":-4.313035,"eighty":-2.964509,"marketCap":95288823},{"date":"2021-05-14","current":-4.558623,"twenty":-6.929504,"median":-4.313035,"eighty":-2.972969,"marketCap":93866602},{"date":"2021-05-21","current":-5.028299,"twenty":-6.917858,"median":-4.333189,"eighty":-2.979684,"marketCap":103537707},{"date":"2021-05-28","current":-5.111183,"twenty":-6.871273,"median":-4.393653,"eighty":-2.98345,"marketCap":105244372},{"date":"2021-06-04","current":-5.152625,"twenty":-6.871273,"median":-4.406671,"eighty":-2.98345,"marketCap":106097705},{"date":"2021-06-11","current":-5.332207,"twenty":-6.862082,"median":-4.441121,"eighty":-2.98345,"marketCap":109795480},{"date":"2021-06-18","current":-5.083555,"twenty":-6.853723,"median":-4.474466,"eighty":-2.999883,"marketCap":104675484},{"date":"2021-06-25","current":-5.415139,"twenty":-6.821696,"median":-4.484072,"eighty":-3.002764,"marketCap":111503126},{"date":"2021-07-02","current":-4.91783,"twenty":-6.821696,"median":-4.517181,"eighty":-3.002764,"marketCap":101263043},{"date":"2021-07-09","current":-4.91783,"twenty":-6.817162,"median":-4.520391,"eighty":-3.002764,"marketCap":101263043},{"date":"2021-07-16","current":-4.544849,"twenty":-6.814048,"median":-4.525978,"eighty":-3.004822,"marketCap":93582980},{"date":"2021-07-23","current":-4.558663,"twenty":-6.813144,"median":-4.542261,"eighty":-3.005507,"marketCap":93867427},{"date":"2021-07-30","current":-4.310009,"twenty":-6.768027,"median":-4.525978,"eighty":-3.014121,"marketCap":88747386},{"date":"2021-08-06","current":-4.296194,"twenty":-6.755203,"median":-4.520391,"eighty":-3.025372,"marketCap":88462939},{"date":"2021-08-13","current":-5.759701,"twenty":-6.708226,"median":-4.520391,"eighty":-3.027649,"marketCap":84800072},{"date":"2021-08-20","current":-5.371842,"twenty":-6.69658,"median":-4.525978,"eighty":-3.027649,"marketCap":79089630},{"date":"2021-08-27","current":-5.779094,"twenty":-6.688933,"median":-4.543555,"eighty":-3.027649,"marketCap":85085594},{"date":"2021-09-03","current":-6.147559,"twenty":-6.679696,"median":-4.546236,"eighty":-3.027649,"marketCap":90510515},{"date":"2021-09-10","current":-5.934237,"twenty":-6.668654,"median":-4.558623,"eighty":-3.027649,"marketCap":87369771},{"date":"2021-09-17","current":-6.031202,"twenty":-6.657551,"median":-4.57079,"eighty":-3.027649,"marketCap":88797382},{"date":"2021-09-24","current":-5.740308,"twenty":-6.647625,"median":-4.571143,"eighty":-3.028316,"marketCap":84514550},{"date":"2021-10-01","current":-5.430021,"twenty":-6.640295,"median":-4.595196,"eighty":-3.035197,"marketCap":79946196},{"date":"2021-10-08","current":-5.255484,"twenty":-6.638349,"median":-4.600065,"eighty":-3.045512,"marketCap":77376497},{"date":"2021-10-15","current":-5.255484,"twenty":-6.638349,"median":-4.61476,"eighty":-3.049661,"marketCap":77376497},{"date":"2021-10-22","current":-5.333056,"twenty":-6.633061,"median":-4.625073,"eighty":-3.049749,"marketCap":78518585},{"date":"2021-10-29","current":-5.119734,"twenty":-6.629535,"median":-4.655883,"eighty":-3.049749,"marketCap":75377842},{"date":"2021-11-05","current":-5.003376,"twenty":-6.603268,"median":-4.664895,"eighty":-3.049749,"marketCap":73664709},{"date":"2021-11-12","current":-4.493596,"twenty":-6.573592,"median":-4.662654,"eighty":-3.050384,"marketCap":70585407},{"date":"2021-11-19","current":-4.002393,"twenty":-6.559225,"median":-4.651352,"eighty":-3.050808,"marketCap":62869593},{"date":"2021-11-26","current":-3.91143,"twenty":-6.546414,"median":-4.625073,"eighty":-3.054203,"marketCap":61440739},{"date":"2021-12-03","current":-3.583961,"twenty":-6.533455,"median":-4.615601,"eighty":-3.064281,"marketCap":56296863},{"date":"2021-12-10","current":-4.238898,"twenty":-6.528828,"median":-4.603452,"eighty":-3.071796,"marketCap":66584615},{"date":"2021-12-17","current":-3.893237,"twenty":-6.521887,"median":-4.595196,"eighty":-3.071849,"marketCap":61154968},{"date":"2021-12-23","current":-3.693117,"twenty":-6.521887,"median":-4.590744,"eighty":-3.071849,"marketCap":58011488},{"date":"2021-12-31","current":-3.383842,"twenty":-6.521887,"median":-4.57079,"eighty":-3.071849,"marketCap":53153383},{"date":"2022-01-07","current":-3.311071,"twenty":-6.521887,"median":-4.564726,"eighty":-3.071849,"marketCap":52010300},{"date":"2022-01-14","current":-3.110951,"twenty":-6.517795,"median":-4.554887,"eighty":-3.071849,"marketCap":48866820},{"date":"2022-01-21","current":-2.783483,"twenty":-6.501428,"median":-4.544849,"eighty":-3.071849,"marketCap":43722944},{"date":"2022-01-28","current":-2.56517,"twenty":-6.493648,"median":-4.53412,"eighty":-3.056373,"marketCap":40293694},{"date":"2022-02-04","current":-2.710712,"twenty":-6.493648,"median":-4.525978,"eighty":-3.049749,"marketCap":42579861},{"date":"2022-02-11","current":-2.692519,"twenty":-6.478297,"median":-4.518786,"eighty":-3.049528,"marketCap":42294090},{"date":"2022-02-18","current":-2.474207,"twenty":-6.469401,"median":-4.493679,"eighty":-3.027649,"marketCap":38864839},{"date":"2022-02-25","current":-2.56517,"twenty":-6.464804,"median":-4.493596,"eighty":-3.027649,"marketCap":40293694},{"date":"2022-03-04","current":-2.401436,"twenty":-6.463655,"median":-4.474466,"eighty":-3.005507,"marketCap":37721756},{"date":"2022-03-11","current":-2.383243,"twenty":-6.463655,"median":-4.4674,"eighty":-3.002188,"marketCap":37435985},{"date":"2022-03-18","current":-2.692519,"twenty":-6.445671,"median":-4.424589,"eighty":-2.98345,"marketCap":42294090},{"date":"2022-03-25","current":-3.182563,"twenty":-6.438135,"median":-4.406707,"eighty":-2.977299,"marketCap":50583658},{"date":"2022-04-01","current":-3.272466,"twenty":-6.437375,"median":-4.399361,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-08","current":-3.326408,"twenty":-6.405363,"median":-4.352398,"eighty":-2.982508,"marketCap":52869925},{"date":"2022-04-14","current":-3.596117,"twenty":-6.373321,"median":-4.313035,"eighty":-2.982508,"marketCap":57156676},{"date":"2022-04-22","current":-3.272466,"twenty":-6.347193,"median":-4.303161,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-29","current":-2.858913,"twenty":-6.326447,"median":-4.268566,"eighty":-2.962474,"marketCap":45439557},{"date":"2022-05-06","current":-2.643146,"twenty":-6.277248,"median":-4.216616,"eighty":-2.953539,"marketCap":42010156},{"date":"2022-05-13","current":-1.934764,"twenty":-6.230731,"median":-4.173408,"eighty":-2.937568,"marketCap":35437139},{"date":"2022-05-20","current":-2.043985,"twenty":-6.230731,"median":-4.135144,"eighty":-2.89691,"marketCap":37437622},{"date":"2022-05-27","current":-2.356043,"twenty":-6.230731,"median":-4.100664,"eighty":-2.893757,"marketCap":43153290},{"date":"2022-06-03","current":-2.387249,"twenty":-6.216696,"median":-4.075277,"eighty":-2.876893,"marketCap":43724857},{"date":"2022-06-10","current":-2.34044,"twenty":-6.180904,"median":-4.058788,"eighty":-2.869844,"marketCap":42867507},{"date":"2022-06-17","current":-2.324837,"twenty":-6.133327,"median":-4.028164,"eighty":-2.855029,"marketCap":42581723},{"date":"2022-06-24","current":-2.278029,"twenty":-6.07916,"median":-4.012846,"eighty":-2.850547,"marketCap":41724373},{"date":"2022-07-01","current":-2.293632,"twenty":-6.019566,"median":-4.004608,"eighty":-2.849536,"marketCap":42010156},{"date":"2022-07-08","current":-2.636896,"twenty":-5.963394,"median":-4.004608,"eighty":-2.830815,"marketCap":48297391},{"date":"2022-07-15","current":-2.580258,"twenty":-5.940997,"median":-3.994243,"eighty":-2.819408,"marketCap":47259997},{"date":"2022-07-22","current":-2.948955,"twenty":-5.928624,"median":-3.973281,"eighty":-2.818063,"marketCap":54013058},{"date":"2022-07-29","current":-2.636896,"twenty":-5.876058,"median":-3.954705,"eighty":-2.806653,"marketCap":48297391},{"date":"2022-08-05","current":-2.652499,"twenty":-5.815779,"median":-3.940978,"eighty":-2.784554,"marketCap":48583174},{"date":"2022-08-12","current":-2.222786,"twenty":-5.766607,"median":-3.93784,"eighty":-2.76529,"marketCap":46342863},{"date":"2022-08-19","current":-2.305111,"twenty":-5.752805,"median":-3.91143,"eighty":-2.755163,"marketCap":48059266},{"date":"2022-08-26","current":-2.016972,"twenty":-5.720382,"median":-3.908675,"eighty":-2.745889,"marketCap":42051857},{"date":"2022-09-02","current":-1.962089,"twenty":-5.670493,"median":-3.900336,"eighty":-2.722463,"marketCap":40907589},{"date":"2022-09-09","current":-1.97581,"twenty":-5.640183,"median":-3.893237,"eighty":-2.714667,"marketCap":41193656},{"date":"2022-09-16","current":-1.797438,"twenty":-5.596232,"median":-3.876372,"eighty":-2.703491,"marketCap":37474784},{"date":"2022-09-23","current":-1.577904,"twenty":-5.526985,"median":-3.862833,"eighty":-2.695817,"marketCap":32897711},{"date":"2022-09-30","current":-1.454415,"twenty":-5.440626,"median":-3.841713,"eighty":-2.690922,"marketCap":30323108},{"date":"2022-10-07","current":-1.481857,"twenty":-5.411208,"median":-3.82533,"eighty":-2.674744,"marketCap":30895242},{"date":"2022-10-14","current":-1.37209,"twenty":-5.371842,"median":-3.811766,"eighty":-2.668102,"marketCap":28606706},{"date":"2022-10-21","current":-1.286334,"twenty":-5.344063,"median":-3.787827,"eighty":-2.661258,"marketCap":26818786},{"date":"2022-10-28","current":-1.357958,"twenty":-5.332588,"median":-3.784081,"eighty":-2.655824,"marketCap":28312056},{"date":"2022-11-04","current":-1.272339,"twenty":-5.288972,"median":-3.765888,"eighty":-2.64511,"marketCap":26526998},{"date":"2022-11-11","current":-1.073658,"twenty":-5.255484,"median":-3.750324,"eighty":-2.637068,"marketCap":26927334},{"date":"2022-11-18","current":-1.198533,"twenty":-5.23884,"median":-3.74716,"eighty":-2.636896,"marketCap":30059218},{"date":"2022-11-25","current":-1.472484,"twenty":-5.218697,"median":-3.714856,"eighty":-2.626865,"marketCap":36929896},{"date":"2022-12-02","current":-1.539373,"twenty":-5.197645,"median":-3.714856,"eighty":-2.621231,"marketCap":38607487},{"date":"2022-12-09","current":-1.518142,"twenty":-5.180271,"median":-3.693117,"eighty":-2.606679,"marketCap":38075009},{"date":"2022-12-16","current":-1.483899,"twenty":-5.158922,"median":-3.655815,"eighty":-2.601296,"marketCap":37216175},{"date":"2022-12-23","current":-1.381167,"twenty":-5.152911,"median":-3.65025,"eighty":-2.594501,"marketCap":34639670},{"date":"2022-12-30","current":-1.209948,"twenty":-5.124997,"median":-3.617947,"eighty":-2.587166,"marketCap":30345496},{"date":"2023-01-06","current":-1.381167,"twenty":-5.124997,"median":-3.585684,"eighty":-2.576597,"marketCap":34639670},{"date":"2023-01-13","current":-1.483899,"twenty":-5.124997,"median":-3.564996,"eighty":-2.56247,"marketCap":37216175},{"date":"2023-01-20","current":-1.461069,"twenty":-5.124997,"median":-3.553341,"eighty":-2.547444,"marketCap":36643618},{"date":"2023-01-27","current":-1.449655,"twenty":-5.121576,"median":-3.536555,"eighty":-2.539774,"marketCap":36357340},{"date":"2023-02-03","current":-1.403996,"twenty":-5.119734,"median":-3.521038,"eighty":-2.528785,"marketCap":35212227},{"date":"2023-02-10","current":-1.337563,"twenty":-5.119734,"median":-3.488735,"eighty":-2.510592,"marketCap":33546087},{"date":"2023-02-17","current":-1.472484,"twenty":-5.114394,"median":-3.483457,"eighty":-2.499636,"marketCap":36929896},{"date":"2023-02-24","current":-1.43824,"twenty":-5.090269,"median":-3.464544,"eighty":-2.493412,"marketCap":36071062},{"date":"2023-03-03","current":-1.381167,"twenty":-5.063718,"median":-3.450298,"eighty":-2.474314,"marketCap":34639670},{"date":"2023-03-10","current":-1.187119,"twenty":-5.04989,"median":-3.434291,"eighty":-2.461859,"marketCap":29772940},{"date":"2023-03-17","current":-1.118631,"twenty":-5.018906,"median":-3.424129,"eighty":-2.456738,"marketCap":28055270},{"date":"2023-03-24","current":-0.996179,"twenty":-5.001753,"median":-3.403043,"eighty":-2.435919,"marketCap":28914105},{"date":"2023-03-31","current":-0.946863,"twenty":-4.988177,"median":-3.395078,"eighty":-2.423552,"marketCap":27482713},{"date":"2023-04-06","current":-0.918154,"twenty":-4.988177,"median":-3.382543,"eighty":-2.408128,"marketCap":26649416},{"date":"2023-04-14","current":-0.946228,"twenty":-4.984446,"median":-3.365649,"eighty":-2.400207,"marketCap":27464280},{"date":"2023-04-20","current":-0.813785,"twenty":-4.984446,"median":-3.362043,"eighty":-2.387249,"marketCap":23620108},{"date":"2023-04-28","current":-0.699041,"twenty":-4.985249,"median":-3.342966,"eighty":-2.356895,"marketCap":20289672},{"date":"2023-05-05","current":-0.79344,"twenty":-4.985249,"median":-3.341543,"eighty":-2.34044,"marketCap":23029605},{"date":"2023-05-12","current":-0.7383,"twenty":-4.986857,"median":-3.328604,"eighty":-2.337487,"marketCap":22202901},{"date":"2023-05-19","current":-0.62569,"twenty":-4.98962,"median":-3.317536,"eighty":-2.324837,"marketCap":18816368},{"date":"2023-05-26","current":-0.615851,"twenty":-4.98962,"median":-3.311071,"eighty":-2.310472,"marketCap":18520485},{"date":"2023-06-02","current":-0.564538,"twenty":-4.98962,"median":-3.294916,"eighty":-2.306159,"marketCap":16977359},{"date":"2023-06-09","current":-0.610621,"twenty":-4.98962,"median":-3.278548,"eighty":-2.29487,"marketCap":18363205},{"date":"2023-06-16","current":-0.582202,"twenty":-4.992383,"median":-3.270745,"eighty":-2.291297,"marketCap":17508550},{"date":"2023-06-23","current":-0.591872,"twenty":-4.995145,"median":-3.259541,"eighty":-2.269684,"marketCap":17799370},{"date":"2023-06-30","current":-0.548552,"twenty":-4.997908,"median":-3.245815,"eighty":-2.262426,"marketCap":16496616},{"date":"2023-07-07","current":-0.564242,"twenty":-4.997908,"median":-3.2383,"eighty":-2.247347,"marketCap":16968456},{"date":"2023-07-14","current":-0.709201,"twenty":-4.997908,"median":-3.227787,"eighty":-2.217051,"marketCap":21327789},{"date":"2023-07-20","current":-0.654434,"twenty":-4.997908,"median":-3.216919,"eighty":-2.20387,"marketCap":19680798},{"date":"2023-07-28","current":-0.641409,"twenty":-5.000671,"median":-3.194941,"eighty":-2.168808,"marketCap":19289081},{"date":"2023-08-04","current":-0.611805,"twenty":-5.001212,"median":-3.177182,"eighty":-2.144839,"marketCap":18398816},{"date":"2023-08-11","current":-0.621673,"twenty":-5.001212,"median":-3.160125,"eighty":-2.07519,"marketCap":18695571},{"date":"2023-08-18","current":-0.586595,"twenty":-5.001212,"median":-3.142523,"eighty":-2.030693,"marketCap":17170815},{"date":"2023-08-25","current":-0.570403,"twenty":-5.001212,"median":-3.122596,"eighty":-2.016133,"marketCap":16696829},{"date":"2023-09-01","current":-0.570301,"twenty":-5.001212,"median":-3.104845,"eighty":-1.965194,"marketCap":16693848},{"date":"2023-09-08","current":-0.397683,"twenty":-5.001212,"median":-3.07346,"eighty":-1.948368,"marketCap":11640977},{"date":"2023-09-15","current":-0.399211,"twenty":-5.001212,"median":-3.065528,"eighty":-1.901704,"marketCap":11685693},{"date":"2023-09-22","current":-0.427726,"twenty":-5.001753,"median":-3.050808,"eighty":-1.79195,"marketCap":12520386},{"date":"2023-09-29","current":-0.430781,"twenty":-5.001753,"median":-3.049749,"eighty":-1.685173,"marketCap":12609817},{"date":"2023-10-06","current":-0.499013,"twenty":-5.001753,"median":-3.027649,"eighty":-1.609459,"marketCap":14607117},{"date":"2023-10-13","current":-0.412959,"twenty":-5.001753,"median":-3.027649,"eighty":-1.577904,"marketCap":12088134},{"date":"2023-10-20","current":-0.626313,"twenty":-5.001753,"median":-3.027649,"eighty":-1.540332,"marketCap":18333422},{"date":"2023-10-27","current":-0.496976,"twenty":-5.003376,"median":-3.028205,"eighty":-1.52385,"marketCap":14547496},{"date":"2023-11-03","current":-0.519585,"twenty":-5.003376,"median":-3.028205,"eighty":-1.506728,"marketCap":15209288},{"date":"2023-11-10","current":-0.547896,"twenty":-5.003376,"median":-3.028205,"eighty":-1.483899,"marketCap":16038018},{"date":"2023-11-17","current":-0.693345,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":18214180},{"date":"2023-11-24","current":-0.636607,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":16723658},{"date":"2023-12-01","current":-0.679388,"twenty":-5.003376,"median":-3.010907,"eighty":-1.454415,"marketCap":17847512},{"date":"2023-12-07","current":-0.6475,"twenty":-5.003376,"median":-3.010907,"eighty":-1.449655,"marketCap":17009838},{"date":"2023-12-15","current":-0.681998,"twenty":-5.005598,"median":-3.005336,"eighty":-1.43824,"marketCap":17916076},{"date":"2023-12-22","current":-0.76007,"twenty":-5.005598,"median":-3.005336,"eighty":-1.426825,"marketCap":19967034},{"date":"2023-12-29","current":-0.851078,"twenty":-5.00782,"median":-3.005443,"eighty":-1.418232,"marketCap":22357832},{"date":"2024-01-05","current":-1.157425,"twenty":-5.010041,"median":-3.00555,"eighty":-1.415411,"marketCap":30405553},{"date":"2024-01-12","current":-0.903555,"twenty":-5.010041,"median":-3.002764,"eighty":-1.401318,"marketCap":23736379},{"date":"2024-01-19","current":-0.701832,"twenty":-5.012263,"median":-2.975134,"eighty":-1.387165,"marketCap":18437125},{"date":"2024-01-26","current":-0.620049,"twenty":-5.010041,"median":-2.962755,"eighty":-1.381167,"marketCap":16288689},{"date":"2024-02-02","current":-0.65757,"twenty":-5.010041,"median":-2.948955,"eighty":-1.37209,"marketCap":17274363},{"date":"2024-02-09","current":-0.627044,"twenty":-5.010041,"median":-2.933352,"eighty":-1.369752,"marketCap":16472459},{"date":"2024-02-16","current":-0.635948,"twenty":-5.010041,"median":-2.903222,"eighty":-1.350843,"marketCap":16706348},{"date":"2024-02-23","current":-0.655026,"twenty":-5.010041,"median":-2.889463,"eighty":-1.324094,"marketCap":17207538},{"date":"2024-03-01","current":-0.800022,"twenty":-5.00782,"median":-2.876227,"eighty":-1.288444,"marketCap":21016585},{"date":"2024-03-08","current":-0.85217,"twenty":-5.00782,"median":-2.858329,"eighty":-1.269059,"marketCap":22386506},{"date":"2024-03-15","current":-0.681227,"twenty":-5.00782,"median":-2.850497,"eighty":-1.216797,"marketCap":17895839},{"date":"2024-03-22","current":-0.562177,"twenty":-5.00782,"median":-2.826724,"eighty":-1.187119,"marketCap":14768402},{"date":"2024-03-28","current":-0.41454,"twenty":-5.00782,"median":-2.819292,"eighty":-1.12548,"marketCap":12340438},{"date":"2024-04-05","current":-0.396581,"twenty":-5.010041,"median":-2.819868,"eighty":-1.084319,"marketCap":11805834},{"date":"2024-04-12","current":-0.356923,"twenty":-5.010041,"median":-2.817081,"eighty":-1.056695,"marketCap":10625251},{"date":"2024-04-19","current":-0.338479,"twenty":-5.010041,"median":-2.808468,"eighty":-0.951218,"marketCap":10076168},{"date":"2024-04-26","current":-0.322368,"twenty":-4.984446,"median":-2.774878,"eighty":-0.942537,"marketCap":9596584},{"date":"2024-05-03","current":-0.385357,"twenty":-4.974094,"median":-2.761076,"eighty":-0.928972,"marketCap":11471707},{"date":"2024-05-10","current":-0.357672,"twenty":-4.974094,"median":-2.747097,"eighty":-0.915662,"marketCap":10647526},{"date":"2024-05-17","current":-0.417701,"twenty":-4.974094,"median":-2.722422,"eighty":-0.898085,"marketCap":11204405},{"date":"2024-05-24","current":-0.427666,"twenty":-4.974094,"median":-2.703367,"eighty":-0.855223,"marketCap":11471707},{"date":"2024-05-31","current":-0.385314,"twenty":-4.974094,"median":-2.697971,"eighty":-0.828803,"marketCap":10335674},{"date":"2024-06-07","current":-0.384337,"twenty":-4.974094,"median":-2.690867,"eighty":-0.797102,"marketCap":10309450},{"date":"2024-06-14","current":-0.374858,"twenty":-4.974094,"median":-2.675203,"eighty":-0.790674,"marketCap":10055181},{"date":"2024-06-21","current":-0.325738,"twenty":-4.974094,"median":-2.668102,"eighty":-0.778182,"marketCap":8737606},{"date":"2024-06-28","current":-0.303333,"twenty":-4.974094,"median":-2.658563,"eighty":-0.774095,"marketCap":8136606},{"date":"2024-07-05","current":-0.312812,"twenty":-4.974094,"median":-2.656134,"eighty":-0.7557,"marketCap":8390875},{"date":"2024-07-12","current":-0.340388,"twenty":-4.974094,"median":-2.64511,"eighty":-0.713305,"marketCap":9130567},{"date":"2024-07-15","current":-0.374858,"twenty":-4.974094,"median":-2.64511,"eighty":-0.711355,"marketCap":10055181},{"date":"2024-08-02","current":-0.195615,"twenty":-4.986857,"median":-2.636896,"eighty":-0.701832,"marketCap":5247186},{"date":"2024-08-09","current":-0.189152,"twenty":-4.986857,"median":-2.625739,"eighty":-0.692211,"marketCap":5073821},{"date":"2024-08-16","current":-0.204821,"twenty":-4.986857,"median":-2.619908,"eighty":-0.672465,"marketCap":5154725},{"date":"2024-08-23","current":-0.510683,"twenty":-4.974094,"median":-2.60347,"eighty":-0.661386,"marketCap":12852365},{"date":"2024-08-30","current":-0.536006,"twenty":-4.974094,"median":-2.594501,"eighty":-0.65757,"marketCap":13489673},{"date":"2024-09-06","current":-0.525455,"twenty":-4.959273,"median":-2.58903,"eighty":-0.654434,"marketCap":13224128},{"date":"2024-09-13","current":-0.512793,"twenty":-4.925805,"median":-2.574402,"eighty":-0.651592,"marketCap":12905474},{"date":"2024-09-20","current":-0.278044,"twenty":-4.917787,"median":-2.562149,"eighty":-0.646935,"marketCap":6997536},{"date":"2024-09-27","current":-0.275784,"twenty":-4.862574,"median":-2.543279,"eighty":-0.644469,"marketCap":6940645},{"date":"2024-10-04","current":-0.278044,"twenty":-4.839659,"median":-2.530279,"eighty":-0.638873,"marketCap":6997536},{"date":"2024-10-11","current":-0.274653,"twenty":-4.839659,"median":-2.512967,"eighty":-0.635948,"marketCap":6912200},{"date":"2024-10-18","current":-0.266741,"twenty":-4.839659,"median":-2.497974,"eighty":-0.628952,"marketCap":6713083},{"date":"2024-10-25","current":-0.287086,"twenty":-4.837049,"median":-2.474207,"eighty":-0.62569,"marketCap":7225098},{"date":"2024-10-31","current":-0.287086,"twenty":-4.752061,"median":-2.460772,"eighty":-0.624124,"marketCap":7225098},{"date":"2024-11-08","current":-0.264481,"twenty":-4.713381,"median":-2.437821,"eighty":-0.621124,"marketCap":6656193},{"date":"2024-11-15","current":-0.291529,"twenty":-4.667079,"median":-2.424759,"eighty":-0.616561,"marketCap":8789588},{"date":"2024-11-22","current":-0.28177,"twenty":-4.667079,"median":-2.401436,"eighty":-0.611805,"marketCap":8495362},{"date":"2024-11-29","current":-0.275796,"twenty":-4.667079,"median":-2.387249,"eighty":-0.604465,"marketCap":8315249},{"date":"2024-12-06","current":-0.248913,"twenty":-4.667079,"median":-2.356043,"eighty":-0.59825,"marketCap":7504737},{"date":"2024-12-13","current":-0.244931,"twenty":-4.667079,"median":-2.338254,"eighty":-0.593495,"marketCap":7384661},{"date":"2024-12-20","current":-0.180213,"twenty":-4.667079,"median":-2.324837,"eighty":-0.589406,"marketCap":5433429},{"date":"2024-12-27","current":-0.176231,"twenty":-4.667079,"median":-2.310472,"eighty":-0.582084,"marketCap":5313354},{"date":"2025-01-03","current":-0.176231,"twenty":-4.667079,"median":-2.306223,"eighty":-0.575062,"marketCap":5313354},{"date":"2025-01-10","current":-0.177226,"twenty":-4.669263,"median":-2.294406,"eighty":-0.570362,"marketCap":5343373},{"date":"2025-01-17","current":-0.173244,"twenty":-4.669263,"median":-2.283926,"eighty":-0.566314,"marketCap":5223297},{"date":"2025-01-24","current":-0.175235,"twenty":-4.669263,"median":-2.265174,"eighty":-0.56442,"marketCap":5283335},{"date":"2025-01-31","current":-0.153331,"twenty":-4.669263,"median":-2.248133,"eighty":-0.562387,"marketCap":4622918},{"date":"2025-02-07","current":-0.083675,"twenty":-4.669263,"median":-2.219202,"eighty":-0.56007,"marketCap":2522792},{"date":"2025-02-14","current":-0.126448,"twenty":-4.669263,"median":-2.168808,"eighty":-0.542573,"marketCap":3812406},{"date":"2025-02-21","current":-0.139391,"twenty":-4.669263,"median":-2.136557,"eighty":-0.53664,"marketCap":4202653},{"date":"2025-02-28","current":-0.126448,"twenty":-4.669263,"median":-2.07519,"eighty":-0.529915,"marketCap":3812406},{"date":"2025-03-07","current":-0.109522,"twenty":-4.671446,"median":-2.030693,"eighty":-0.519911,"marketCap":3302084},{"date":"2025-03-14","current":-0.115496,"twenty":-4.671446,"median":-2.016972,"eighty":-0.508863,"marketCap":3482198},{"date":"2025-03-21","current":-0.108526,"twenty":-4.671446,"median":-2.016972,"eighty":-0.50182,"marketCap":3272065},{"date":"2025-03-28","current":-0.675482,"twenty":-4.671446,"median":-1.96597,"eighty":-0.498418,"marketCap":14700518},{"date":"2025-04-04","current":-0.558849,"twenty":-4.671446,"median":-1.948368,"eighty":-0.498418,"marketCap":12162229},{"date":"2025-04-11","current":-0.470329,"twenty":-4.638525,"median":-1.875116,"eighty":-0.493187,"marketCap":10235761},{"date":"2025-04-17","current":-0.591208,"twenty":-4.595196,"median":-1.701084,"eighty":-0.493187,"marketCap":12866453},{"date":"2025-04-25","current":-0.714081,"twenty":-4.566151,"median":-1.609459,"eighty":-0.49288,"marketCap":15540548},{"date":"2025-05-02","current":-0.649749,"twenty":-4.553113,"median":-1.577904,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-09","current":-0.649749,"twenty":-4.553113,"median":-1.539373,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-16","current":-0.549617,"twenty":-4.475418,"median":-1.506728,"eighty":-0.49288,"marketCap":12767050},{"date":"2025-05-23","current":-0.566372,"twenty":-4.368028,"median":-1.483899,"eighty":-0.49288,"marketCap":13156264},{"date":"2025-05-30","current":-0.547146,"twenty":-4.296194,"median":-1.483784,"eighty":-0.49288,"marketCap":12709648},{"date":"2025-06-06","current":-0.419707,"twenty":-4.228663,"median":-1.472484,"eighty":-0.489644,"marketCap":9749383},{"date":"2025-06-13","current":-0.406571,"twenty":-4.002393,"median":-1.461069,"eighty":-0.464266,"marketCap":9444229},{"date":"2025-06-20","current":-0.354571,"twenty":-3.940538,"median":-1.449655,"eighty":-0.442788,"marketCap":8236329},{"date":"2025-06-27","current":-0.195835,"twenty":-3.816828,"median":-1.43824,"eighty":-0.430985,"marketCap":4549053},{"date":"2025-07-03","current":-0.352742,"twenty":-3.765888,"median":-1.426825,"eighty":-0.427024,"marketCap":8193836},{"date":"2025-07-11","current":-0.554012,"twenty":-3.725864,"median":-1.415411,"eighty":-0.422336,"marketCap":12869143},{"date":"2025-07-18","current":-1.086632,"twenty":-3.615274,"median":-1.409703,"eighty":-0.422336,"marketCap":25241381},{"date":"2025-07-25","current":-0.828369,"twenty":-3.530431,"median":-1.392582,"eighty":-0.422336,"marketCap":19242173},{"date":"2025-08-01","current":-0.816665,"twenty":-3.455744,"median":-1.381167,"eighty":-0.422336,"marketCap":18970306},{"date":"2025-08-08","current":-0.880906,"twenty":-3.401293,"median":-1.37209,"eighty":-0.422336,"marketCap":20462556},{"date":"2025-08-15","current":-0.73896,"twenty":-3.383274,"median":-1.369752,"eighty":-0.422336,"marketCap":19619379},{"date":"2025-08-22","current":-0.680669,"twenty":-3.383274,"median":-1.35734,"eighty":-0.422336,"marketCap":18071756},{"date":"2025-08-29","current":-0.448418,"twenty":-3.383274,"median":-1.324094,"eighty":-0.422336,"marketCap":11905492},{"date":"2025-09-05","current":-0.432334,"twenty":-3.383842,"median":-1.28985,"eighty":-0.421853,"marketCap":11478457},{"date":"2025-09-12","current":-0.520301,"twenty":-3.383274,"median":-1.271378,"eighty":-0.422336,"marketCap":13813999},{"date":"2025-09-19","current":-0.570117,"twenty":-3.383274,"median":-1.224623,"eighty":-0.422336,"marketCap":15136616},{"date":"2025-09-26","current":-0.819756,"twenty":-3.383274,"median":-1.190488,"eighty":-0.422336,"marketCap":21764523},{"date":"2025-10-03","current":-0.932177,"twenty":-3.383274,"median":-1.124338,"eighty":-0.422336,"marketCap":24749288},{"date":"2025-10-10","current":-0.962193,"twenty":-3.383274,"median":-1.08551,"eighty":-0.422336,"marketCap":25546215},{"date":"2025-10-17","current":-0.899364,"twenty":-3.383274,"median":-1.070018,"eighty":-0.422336,"marketCap":23878113},{"date":"2025-10-24","current":-0.914279,"twenty":-3.383274,"median":-1.021953,"eighty":-0.422336,"marketCap":24274101},{"date":"2025-10-31","current":-0.842315,"twenty":-3.383274,"median":-0.97515,"eighty":-0.422336,"marketCap":22363456},{"date":"2025-11-07","current":-0.851077,"twenty":-3.383274,"median":-0.95082,"eighty":-0.422336,"marketCap":22596099},{"date":"2025-11-14","current":-0.84623,"twenty":-3.383274,"median":-0.946546,"eighty":-0.422336,"marketCap":22467403},{"date":"2025-11-21","current":-0.417396,"twenty":-3.383274,"median":-0.935191,"eighty":-0.420044,"marketCap":21458765},{"date":"2025-11-28","current":-0.270045,"twenty":-3.383274,"median":-0.928079,"eighty":-0.418029,"marketCap":13883286},{"date":"2025-12-05","current":-0.305397,"twenty":-3.380203,"median":-0.924038,"eighty":-0.414937,"marketCap":15700790},{"date":"2025-12-12","current":-0.198053,"twenty":-3.380203,"median":-0.91642,"eighty":-0.409901,"marketCap":10182095},{"date":"2025-12-19","current":-0.229509,"twenty":-3.380203,"median":-0.912974,"eighty":-0.40792,"marketCap":11799264},{"date":"2025-12-26","current":-0.233703,"twenty":-3.380203,"median":-0.905143,"eighty":-0.406728,"marketCap":12014917},{"date":"2026-01-02","current":-0.198348,"twenty":-3.380203,"median":-0.900389,"eighty":-0.403557,"marketCap":10197275},{"date":"2026-01-09","current":-0.246166,"twenty":-3.380203,"median":-0.893492,"eighty":-0.397276,"marketCap":12655631},{"date":"2026-01-16","current":-0.255749,"twenty":-3.358773,"median":-0.88622,"eighty":-0.39284,"marketCap":13148307},{"date":"2026-01-23","current":-0.285696,"twenty":-3.329922,"median":-0.873415,"eighty":-0.38937,"marketCap":14687922},{"date":"2026-01-30","current":-0.256348,"twenty":-3.272466,"median":-0.859078,"eighty":-0.385323,"marketCap":13179100},{"date":"2026-02-06","current":-0.234187,"twenty":-3.237941,"median":-0.851624,"eighty":-0.378965,"marketCap":12039785},{"date":"2026-02-13","current":-0.252515,"twenty":-3.216194,"median":-0.835718,"eighty":-0.37563,"marketCap":12982029},{"date":"2026-02-17","current":-0.259942,"twenty":-3.196948,"median":-0.830495,"eighty":-0.375032,"marketCap":13363853}],"updateTime":1771418378454},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612449226","title":"BRIEF-Moleculin Miracle Trial Delivers 40% Preliminary Blinded CRc Rate (N=30)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612449226","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612449226?lang=en_us&edition=fundamental","pubTime":"2026-02-18 22:13","pubTimestamp":1771424001,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Miracle Trial Delivers 40% Preliminary Blinded CRc Rate (N=30)Feb 18 (Reuters) - Moleculin Biotech Inc MBRX.O:MOLECULIN MIRACLE TRIAL DELIVERS 40% PRELIMINARY BLINDED CRC RATE (N=30)MO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZD1DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2612544680","title":"Moleculin Biotech Inc - Reports 40% Preliminary Crc Rate in Miracle Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612544680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612544680?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:20","pubTimestamp":1771420829,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZD1DU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2612446809","title":"Moleculin Biotech Inc - Expects Recruitment of First 45 Subjects by Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612446809?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:20","pubTimestamp":1771420829,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZD1DU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2612386446","title":"Moleculin MIRACLE trial reports 40% preliminary blinded CRc rate in relapsed or refractory AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2612386446","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612386446?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:20","pubTimestamp":1771420815,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. reported a preliminary, blinded composite complete remission  rate of 40%  in the first 30 treated patients in its pivotal Phase 2B/3 MIRACLE trial evaluating annamycin  plus cytarabine versus cytarabine plus placebo in adults with relapsed or refractory acute myeloid leukemia after one prior induction therapy. As of Feb. 10, 2026, 35 subjects had been treated, with the company targeting treatment of the first 45 subjects in Q1 2026; unblinding of efficacy and safety data for those 45 subjects is expected in late Q2 2026 following data entry, audit, and data lock. A second unblinding for the full 90 subjects in Part A is expected in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL2SvDgn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","NDAQ","SG9999014013.SGD","LU2210150020.SGD","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","SG9999014021.USD","SG9999014039.USD","LU0314104364.USD","BK4588","LU2210149790.SGD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2612574834","title":"Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2612574834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612574834?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:35","pubTimestamp":1771335314,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2612457488","title":"Moleculin Biotech Receives Notice of Allowance for Japanese Patent Covering Liposomal Annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2612457488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612457488?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:35","pubTimestamp":1771335311,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. announced that the Japan Patent Office has issued a notice of allowance for its patent application titled \"METHOD OF RECONSTITUTING LIPOSOMAL ANNAMYCIN.\" A patent from the application is expected to be issued in the coming months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDLbSx9tX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU0314104364.USD","SG9999014039.USD","BK4112","SG9999014005.SGD","SG9999014013.SGD","BK4585","IE00BKPKM429.USD","LU2095319765.USD","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4588","MBRX","LU2210150020.SGD","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ"],"gpt_icon":0},{"id":"2611515772","title":"Moleculin Biotech Inc. Launches CEO Corner to Enhance Stakeholder Communication and Outlines Plans to Advance Lead Clinical Programs and Pipeline Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2611515772","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611515772?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:32","pubTimestamp":1770989531,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. Launches CEO Corner to Enhance Stakeholder Communication and Outlines Plans to Advance Lead Clinical Programs and Pipeline Development. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire  on February 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDLbnFzRq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","SG9999014021.USD","SG9999014005.SGD","BK4588","SG9999014013.SGD","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","BK4139","LU2210149790.SGD","LU0314104364.USD","BK4112","MBRX","IE00BGHQF748.EUR","LU2210150020.SGD"],"gpt_icon":0},{"id":"2609006433","title":"Moleculin Biotech Inc. Held Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2609006433","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609006433?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:55","pubTimestamp":1770310542,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. held a Special Meeting of Stockholders on February 5, 2026. Stockholders approved the issuance of up to 2,610,823 shares of common stock upon the exercise of certain warrants issued on December 11, 2025. A proposal to amend the company’s name from Moleculin Biotech, Inc. to Moleculin Inc. was not approved. Stockholders approved an adjournment of the meeting, if necessary, to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7qSXB3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2609306717","title":"Moleculin Biotech nimmt an virtueller Corporate-Connect-Konferenz von Webull Financial teil","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306717","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306717?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:15","pubTimestamp":1770300910,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. wird am Mittwoch, den 11. Februar 2026, um 13:20 Uhr EST an der virtuellen Corporate Connect Webinar Series von Webull Financial teilnehmen. CEO Walter Klemp wird das Unternehmen prsentieren.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL3C6dPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4127","LU2095319765.USD","BK4585","BK4112","LU2210150020.SGD","BK4588","MBRX","SG9999014005.SGD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD"],"gpt_icon":0},{"id":"2603768709","title":"BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2603768709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603768709?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:09","pubTimestamp":1768313362,"startTime":"0","endTime":"0","summary":"BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials** Shares of drug developer Moleculin Biotech MBRX.O rise 2.2% to $4.14 premarket ** Co says its experimental cancer drug, annamycin, showed no signs of causing heart damage in patients in five clinical trials** Independent expert reviewed data from 90 patients with leukemia and sarcoma; found no heart issues - MBRX** Annamycin, also called naxtarubicin, tested for leukemia and sarcoma spread** Leukemia is a blood cancer; sarcoma is a cancer that starts in soft tissues and can spread to lungs** Drug being studied alone and with chemotherapy; late-stage leukemia trial ongoing - MBRX** Co says it is working to secure funding and will monitor patients long-term for heart issues** As of last close, stock down ~92% over the past year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE1BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2603068731","title":"Moleculin Biotech Reports Annamycin Shows No Cardiotoxicity in 90 Clinical Trial Subjects","url":"https://stock-news.laohu8.com/highlight/detail?id=2603068731","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603068731?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:55","pubTimestamp":1768312515,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. announced that an independent assessment has confirmed the absence of cardiotoxicity in 90 subjects treated with Annamycin, a next-generation anthracycline, across five clinical trials. The reviewed data included subjects with acute myeloid leukemia  and soft tissue sarcoma  treated with Annamycin as monotherapy and in combination with cytarabine at multiple sites in the United States and European Union. The assessment, conducted by an expert affiliated with a leading cancer research institute, found no evidence of cardiotoxicity based on serial ECGs, echocardiography, and cardiac biomarker analysis. Most subjects received doses above the FDA-recommended lifetime maximum for other anthracyclines. These results have already been assessed and reported by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL2hYY4d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4139","IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","NDAQ","SG9999014039.USD","MBRX","BK4585","SG9999014021.USD","LU2210149790.SGD","BK4112","SG9999014013.SGD","BK4588"],"gpt_icon":0},{"id":"2602480665","title":"BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2602480665","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602480665?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:41","pubTimestamp":1768225306,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical ProgramsJan 12 (Reuters) - Moleculin Bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2602467548","title":"Moleculin Biotech Inc - First Miracle Trial Unblinding Expected Q1 2026; Global Trial NOW Spans Nine Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2602467548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602467548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2602414548","title":"Moleculin Biotech Inc - Primary Efficacy Data for Miracle Expected in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2602414548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602414548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224960,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2601218809","title":"BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2601218809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601218809?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:24","pubTimestamp":1767795878,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance Jan 7 (Reuters) - Moleculin Biotech Inc MBRX.O:MOLECULIN BIOTECH INC - REGAINS NASDAQ LISTING COMPLIANCE - SEC FILINGSource text: [ID:n0001437749-26-000695]Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2601480525","title":"Moleculin Biotech Inc - Regains Nasdaq Listing Compliance - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601480525?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:33","pubTimestamp":1767792787,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592190604","title":"Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592190604","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592190604?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:37","pubTimestamp":1766180224,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced a Special Meeting of Stockholders to be held on February 5, 2026. Among the proposals to be voted on are the Nasdaq Proposal, a Name Change Proposal, and an Adjournment Proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL68MPly:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592918178","title":"Moleculin Reports Positive Phase 1 Results for WP1066 in Pediatric Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918178","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918178?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978266,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced positive results from a Phase 1 clinical trial evaluating WP1066 for the treatment of pediatric recurrent malignant brain tumors. The trial, conducted at the Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and led by Dr. Tobey MacDonald, demonstrated that WP1066 induces anti-tumor immune responses. The results, which found WP1066 to be safe and effective, were recently published in the Journal of Clinical Investigation Insight and support the advancement to a Phase 2 trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2L4hf3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592918925","title":"Moleculin Biotech Inc - WP1066 Found Safe and Effective, Warranting Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918925?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6QLSKT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592918904","title":"Moleculin Announces Positive Results From Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918904?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6QLSKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}